TipRanks
Go Ultimate55% OFF

ALPS Group (ALPS) Stock Price & Analysis

ALPS Stock Chart & Stats

$0.33$0.00(0.31%)
At close: 4:00 PM EDT
$0.3$0.35$0.4$0.453 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$0.32 - $0.33
52-Week Range
$0.23 - $2.90
Previous Close
$0.32
Volume
N/A
Average Volume (3M)
39.50K
Market Cap
$54.08M
Enterprise Value
$121.70T
Total Cash (Recent Filing)
$357.73K
Total Debt (Recent Filing)
$5.91M
Price to Earnings (P/E)
―
Beta
0.30
Next Earnings
N/A
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

The 44% revenue increase shows that Alps is expanding across several operating businesses rather than relying on a single activity. Continued growth in therapy, testing, laboratory and aesthetics services could broaden the commercial base and support greater scale over the next several quarters.

Focused Platform Strategy

Concentrating resources on priority programs can improve execution by reducing distractions and directing research spending toward platforms with greater strategic relevance. Progress in NK-cell and exosome programs may strengthen the company’s longer-term precision-medicine positioning if development continues.

Expanded Diagnostic Capabilities

Whole genome sequencing accreditation and the planned organoid platform expand Alps’ capabilities across diagnostics and translational research. These assets can deepen its integrated healthcare offering, support more sophisticated testing and create additional opportunities within regional precision medicine.

Bears Say

Persistent Losses

Revenue growth has not yet translated into sustainable profitability, as deeply negative net margins and continuing operating losses show that the business remains economically pressured. Without improvement in operating leverage or gross margin, future expansion may continue requiring external financial support.

Ongoing Cash Burn

Negative operating and free cash flow mean Alps is not currently self-funding its activities, even though free cash flow improved year over year. Continued cash outflows can constrain investment in growth programs and increase reliance on future financing to sustain operations.

Negative Equity And Leverage Risk

The shift from positive equity in 2024 to negative equity in 2025 and 2026 materially weakens the capital structure. Combined with sizeable debt, this reduces financial flexibility and can make it harder to absorb setbacks or fund strategic initiatives on favorable terms.

ALPS Group News

ALPS FAQ

What was ALPS Group’s price range in the past 12 months?
ALPS Group lowest stock price was $0.23 and its highest was $2.90 in the past 12 months.
What is ALPS Group’s market cap?
ALPS Group’s market cap is $54.08M.
When is ALPS Group’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ALPS Group’s earnings last quarter?
ALPS Group released its earnings results on Aug 07, 2026. The company reported -$0.02 earnings per share for the quarter.
Is ALPS Group overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does ALPS Group pay dividends?
ALPS Group pays a ― dividend of $0.032 which represents an annual dividend yield of ―. See more information on ALPS Group dividends here
What is ALPS Group’s EPS estimate?
ALPS Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ALPS Group have?
ALPS Group has 166,400,310 shares outstanding.
What happened to ALPS Group’s price movement after its last earnings report?
ALPS Group reported an EPS of -$0.02 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ALPS Group?
Hedge funds hold ALPS Group shares: the largest hedge-fund position in ALPS Group is 70,136,916 shares, and hedge funds decreased their holdings by 14.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology